410 results on '"Yu, Xian Jun"'
Search Results
2. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer
3. The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer
4. A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer
5. The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis
6. Hernandezine induces autophagic cell death in human pancreatic cancer cells via activation of the ROS/AMPK signaling pathway
7. Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma
8. Laparoscopic pancreaticoduodenectomy with portal or superior mesenteric vein resection and reconstruction for pancreatic cancer: A single-center experience
9. A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancer
10. Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer
11. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications
12. Development and multicenter validation of a nomogram for preoperative prediction of lymph node positivity in pancreatic cancer (NeoPangram)
13. Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation
14. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation
15. Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer
16. Cancer-associated fibroblasts in therapeutic resistance of pancreatic cancer: Present situation, predicaments, and perspectives
17. A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors
18. Killing the “BAD”: Challenges for immunotherapy in pancreatic cancer
19. Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
20. Development and Validation of a New Nomogram for Predicting Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy
21. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer
22. The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms
23. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway
24. Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma
25. Reflections on depletion of tumor stroma in pancreatic cancer
26. Comments on “Importance of Normalization of CA19-9 Levels After Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer”
27. Comment on “Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines”
28. Comment on “Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment”
29. Comment on “Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma”
30. Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma
31. A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC-TNM staging
32. The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis
33. Strategies for pancreatic anastomosis after pancreaticoduodenectomy: What really matters?
34. Comments on “Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients with Localized Pancreatic Cancer”
35. Comment on “Prognosis-Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines”
36. Comment on “Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival with or without Liver Treatment”
37. Angiogenesis in pancreatic cancer: current research status and clinical implications
38. Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma
39. Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma
40. Inhibition of Epithelial‐to‐Mesenchymal Transition Augments Antitumor Efficacy of Nanotherapeutics in Pancreatic Ductal Adenocarcinoma
41. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma
42. Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
43. Intrinsic Contact Between T and N Classifications in Resected Well–Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms
44. Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer
45. Data from A Novel Regulatory Mechanism of Pim-3 Kinase Stability and Its Involvement in Pancreatic Cancer Progression
46. Supplementary Tables 1 through 3 from A Novel Regulatory Mechanism of Pim-3 Kinase Stability and Its Involvement in Pancreatic Cancer Progression
47. Supplementary Figure 1 from A Novel Regulatory Mechanism of Pim-3 Kinase Stability and Its Involvement in Pancreatic Cancer Progression
48. Supplementary Materials and Methods from A Novel Regulatory Mechanism of Pim-3 Kinase Stability and Its Involvement in Pancreatic Cancer Progression
49. The Surgical and Therapeutic Activities of Non-Functional Pancreatic Neuroendocrine Tumors at a High-Volume Institution
50. ASO Author Reflections: Tumor-Infiltrating NETs are New Biomarkers to Predict Postsurgical Survival for Patients with Pancreatic Ductal Adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.